{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:02:52Z","timestamp":1757617372512,"version":"3.44.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej25-0055","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T18:07:31Z","timestamp":1747332451000},"page":"1023-1030","source":"Crossref","is-referenced-by-count":1,"title":["Sarcopenia in children with acute leukemia worsened after induction therapy"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-5356","authenticated-orcid":false,"given":"Tomoyo","family":"Itonaga","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumika","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-7004","authenticated-orcid":false,"given":"Naoki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-1088","authenticated-orcid":false,"given":"Souichi","family":"Suenobu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"},{"name":"NHO Nishibeppu National Hospital, Oita 874-0840, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-1991","authenticated-orcid":false,"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University Faculty of Medicine, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39: 412\u2013423.","DOI":"10.1093\/ageing\/afq034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, et al. (2017) ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 36: 49\u201364.","DOI":"10.1016\/j.clnu.2016.09.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, et al. (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12: 249\u2013256.","DOI":"10.1016\/j.jamda.2011.01.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Orsso CE, Tibaes JRB, Oliveira CLP, Rubin DA, Field CJ, et al. (2019) Low muscle mass and strength in pediatrics patients: Why should we care? Clin Nutr 38: 2002\u20132015.","DOI":"10.1016\/j.clnu.2019.04.012"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381: 752\u2013762.","DOI":"10.1016\/S0140-6736(12)62167-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Gilligan LA, Towbin AJ, Dillman JR, Somasundaram E, Trout AT (2020) Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults. Pediatr Radiol 50: 455\u2013464.","DOI":"10.1007\/s00247-019-04562-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Shachar SS, Williams GR, Muss HB, Nishijima TF (2016) Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer 57: 58\u201367.","DOI":"10.1016\/j.ejca.2015.12.030"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ritz A, Froeba-Pohl A, Kolorz J, Vigodski V, Hubertus J, et al. (2021) Total psoas muscle area as a marker for sarcopenia is related to outcome in children with neuroblastoma. Front Surg 8: 718184.","DOI":"10.3389\/fsurg.2021.718184"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kudo W, Terui K, Furugane R, Takenouchi A, Komatsu S, et al. (2024) Clinical significance of sarcopenia in children with neuroblastic tumors. Pediatr Surg Int 40: 237.","DOI":"10.1007\/s00383-024-05815-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kawakubo N, Kinoshita Y, Souzaki R, Koga Y, Oba U, et al. (2019) The influence of sarcopenia on high-risk neuroblastoma. J Surg Res 236: 101\u2013105.","DOI":"10.1016\/j.jss.2018.10.048"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Nakamura N, Kishimoto K, Ishida T, Nakamura S, Tamura A, et al. (2021) Muscle mass change during chemotherapy in children with high-risk neuroblastoma: a retrospective case series of 24 patients. Eur J Pediatr 180: 3265\u20133271.","DOI":"10.1007\/s00431-021-04106-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lurz E, Patel H, Lebovic G, Quammie C, Woolfson JP, et al. (2020) Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 11: 405\u2013414.","DOI":"10.1002\/jcsm.12514"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Priego T, Mart\u00edn AI, Gonz\u00e1lez-Hedstr\u00f6m D, Granado M, L\u00f3pez-Calder\u00f3n A (2021) Role of hormones in sarcopenia. Vitam Horm 115: 535\u2013570.","DOI":"10.1016\/bs.vh.2020.12.021"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Suenobu S, Goto H, Hirano N, Sonoda T, Izumi T, et al. (2020) Early recovery of height velocity in prepubertal children with acute lymphoblastic leukemia treated by a short intensive phase without cranial radiation therapy. J Pediatr Hematol Oncol 42: 271\u2013274.","DOI":"10.1097\/MPH.0000000000001695"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sakamoto K, Imamura T, Kihira K, Suzuki K, Ishida H, et al. (2018) Low incidence of osteonecrosis in childhood acute lymphoblastic leukemia treated with ALL-97 and ALL-02 study of Japan Association of Childhood Leukemia Study Group. J Clin Oncol 36: 900\u2013907.","DOI":"10.1200\/JCO.2017.75.5066"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Rayar M, Webber CE, Nayiager T, Sala A, Barr RD (2013) Sarcopenia in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 35: 98\u2013102.","DOI":"10.1097\/MPH.0b013e318279eea2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Suzuki D, Kobayashi R, Sano H, Hori D, Kobayashi K (2018) Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance. Int J Hematol 107: 486\u2013489.","DOI":"10.1007\/s12185-017-2388-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Verwaaijen EJ, van der Torre P, Vormoor J, Pieters R, Fiocco M, et al. (2023) Novel adaption of the SARC-F score to classify pediatric hemato-oncology patients with functional sarcopenia. Cancers (Basel) 15: 320.","DOI":"10.3390\/cancers15010320"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bolier M, de Winter DTC, Pluimakers VG, Fiocco M, van den Berg SAA, et al. (2025) Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study. Cancer 131: e35681.","DOI":"10.1002\/cncr.35681"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Benson AC, Torode ME, Singh MA (2006) Muscular strength and cardiorespiratory fitness is associated with higher insulin sensitivity in children and adolescents. Int J Pediatr Obes 1: 222\u2013231.","DOI":"10.1080\/17477160600962864"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Nielsen MKF, Christensen JF, Frandsen TL, Thorsteinsson T, Andersen LB, et al. (2020) Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial. BMC Med 18: 175.","DOI":"10.1186\/s12916-020-01634-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Fridh MK, Schmidt-Andersen P, Andr\u00e9s-Jensen L, Thorsteinsson T, Wehner PS, et al. (2025) Children with cancer and their cardiorespiratory fitness and physical function-the long-term effects of a physical activity program during treatment: a multicenter non-randomized controlled trial. J Cancer Surviv 19: 672\u2013684.","DOI":"10.1007\/s11764-023-01499-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Morales JS, Padilla JR, Valenzuela PL, Santana-Sosa E, Rinc\u00f3n-Castanedo C, et al. (2018) Inhospital exercise training in children with cancer: does it work for all? Front Pediatr 6: 404.","DOI":"10.3389\/fped.2018.00404"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0055\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:33:40Z","timestamp":1757129620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0055\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0055","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ25-0055"}}